SCHEMBL1632138

SCHEMBL1632138

C=NNC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337498 0.67
SCHEMBL337497 0.67
SCHEMBL3270492 0.64
SCHEMBL10078424 0.64
SCHEMBL3069183 0.61
SCHEMBL1632136 0.61
SCHEMBL2229482 0.61
SCHEMBL27636832 0.61
SCHEMBL16068099 0.59
SCHEMBL8337792 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293495-A1 BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-12-20 US claimed
WO-2007130712-A1 SUBSTITUTED DIPIPERIDINE AS CCR2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES JANSSEN PHARMACEUTICA, NV (BE) 2007-11-15 WO claimed
US-20070197590-A1 SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTCA N.V. (BE) 2007-08-23 US claimed
US-20060241302-A1 Morpholine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-10-26 US claimed
EP-1640366-A1 HETEROCYCLIC METHYL SULFONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-03-29 EP claimed
US-20050234109-A1 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine DAIICHI PHARMACEUTICAL CO. LTD. (JP) 2005-10-20 US claimed
EP-1466898-A1 BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-10-13 EP claimed
EP-0322691-B1 Process for producing 1-acyl-2-pyrazoline derivatives MITSUI TOATSU CHEMICALS (JP) 1994-06-15 EP claimed
WO-2025041102-A1 TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES BRIGHT PEAK THERAPEUTICS AG (CH) 2025-02-27 WO disclosed
EP-4366778-A1 ANTIBODY CONJUGATES AND MANUFACTURE THEREOF Bright Peak Therapeutics AG (CH) 2024-05-15 EP disclosed
WO-2023281481-A1 ANTIBODY CONJUGATES AND MANUFACTURE THEREOF BRIGHT PEAK THERAPEUTICS (CH) 2023-01-12 WO disclosed
US-20210393557-A1 Regulators of the Endoplasmic Reticulum Proteostasis Network THE SCRIPPS RESEARCH INSTITUTE 2021-12-23 US disclosed
US-11135186-B2 Regulators of the endoplasmic reticulum proteostasis network THE SCRIPPS RESEARCH INSTITUTE (US) 2021-10-05 US disclosed
US-20200109263-A1 TIRE RUBBER COMPOSITION AND TIRE BRIDGESTONE CORPORATION (JP) 2020-04-09 US disclosed
EP-1149094-B1 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS BASILEA PHARMACEUTICA AG (CH) 2004-04-21 EP disclosed
US-6376491-B1 BENZOFURAN DERIVATIVES FOR TREATMENT OR PREVENTION OF MYCOSIS IN MAMMALS BASILEA PHARMACEUTICA AG (CH) 2002-04-23 US disclosed
EP-1149094-A2 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS Basilea Pharmaceutica AG (CH) 2001-10-31 EP disclosed
WO-2000037464-A2 4-(AMINOALKOXY)BENZOFURANS AS N-MYRISTOYLTRANSFERASE INHIBITORS BASILEA PHARMACEUTICA AG (CH) 2000-06-29 WO disclosed
US-5629332-A FUNGICIDES NIHON NOHYAKU CO., LTD. (JP) 1997-05-13 US disclosed
EP-0679647-A1 Novel antifungal triazole compound and production and use thereof NIHON NOHYAKU CO., LTD. (JP) 1995-11-02 EP disclosed